10 new technologies tackling urgent challenges from autoimmune disease to cancer win funding from Blavatnik Biomedical Accelerator.

Axoft, a startup launched with technology developed in Harvard labs, is transforming care for traumatic brain injuries with its soft, biocompatible neural probe that can quickly measure recovery and consciousness within a few minutes.

Three research projects that address urgent societal challenges — cardiovascular health, rising data demands, and the future of quantum computation — have been named Harvard Grid Accelerator awardees and will receive funding, mentorship, and venture development.

Bioengineering researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a soft, thin, stretchable bioelectronic device that can be implanted into a tadpole embryo’s brain and record electrical activity with no impact on normal tadpole embryo development or behavior. This novel device could help researchers better understand and treat diseases that manifest in early brain development.